We give you a written timeline estimate for your case before you commit.Ask about Jascayd
Is Jascayd available in Qatar? Status, route and cost
A plain answer for families in Qatar, checked against FDA, regulator and manufacturer sources on 17 October 2026.
Reviewed by the Reserve Meds clinical operations team on 17 October 2026.
Is Jascayd available in Qatar?
We could not confirm Jascayd's status in Qatar, because we found no public drug register. Jascayd is a twice-daily tablet for idiopathic and progressive pulmonary fibrosis. If it is not registered, the treating hospital asks the Ministry of Public Health for approval to import it for the patient, using the FDA approval as the reference.
- Registration: Not confirmed; we found no public drug register for Qatar.
- Access route: Hospital import request to MoPH for one named patient, using the FDA approval.
- Who acts: your treating hospital in Qatar, through MoPH, on the request of your treating specialist.
- Timeline: We give you a written timeline estimate for your case before you commit.
- Price: Medicine price: quote on request. You get a written quote for your case before you commit.
Status in Qatar, with dates
- No public, searchable Qatar drug register was found, so registration is not confirmed (checked 17 October 2026). (source)
- In the region, Jascayd has two active codes in the Abu Dhabi Department of Health drug code list (C81-E631-20994-01 and C81-E631-21071-01), release of 26 September 2026. (source)
- FDA approval for IPF on 7 October 2025. (source)
- FDA approval for PPF in December 2025. (source)
What Jascayd is
Jascayd (nerandomilast) is a tablet made by Boehringer Ingelheim. It is a phosphodiesterase 4B (PDE4B) inhibitor. The FDA approved it on 7 October 2025 for idiopathic pulmonary fibrosis (IPF) in adults, and in December 2025 for progressive pulmonary fibrosis (PPF) in adults. The pivotal trial for PPF was FIBRONEER-ILD.
Pulmonary fibrosis is scarring of the lungs that makes breathing harder over time. Jascayd is a long-term treatment that a lung specialist starts and follows up.
How it is given and safety
The usual dose is 18 mg by mouth twice daily, about 12 hours apart, with or without food. The tablet can be swallowed whole or dispersed in water. The dose is lowered to 9 mg twice daily for people who cannot tolerate 18 mg (but not for people also taking pirfenidone, who stay on 18 mg) and for people taking strong CYP3A inhibitors. Tablets come in 9 mg and 18 mg strengths.
The US label lists no contraindications. Common side effects reported by Boehringer Ingelheim include diarrhea, COVID-19, upper respiratory infections, depression, weight loss, decreased appetite, nausea, tiredness, headache, vomiting, back pain and dizziness. Diarrhea was more frequent in people also taking nintedanib, and it was the most common reason to stop treatment.
How access works in Qatar
In Qatar, the Ministry of Public Health (MoPH), through its Department of Pharmacy and Drug Control, supervises the registration and importation of medicines.
For a medicine that is not registered in Qatar, the treating hospital asks MoPH for approval to import it for the patient. Your hospital pharmacy prepares the request and confirms the current MoPH procedure.
Ask the hospital pharmacy to confirm the current status with MoPH's Department of Pharmacy and Drug Control before anything is filed.
Who does what
- Your treating specialist decides whether Jascayd is right for the patient and writes the clinical letter and prescription.
- The hospital files the import request, receives the medicine and dispenses it to the patient.
- The Ministry of Public Health (MoPH) registers medicines and decides on any import request for a medicine that is not registered.
- Boehringer Ingelheim makes Jascayd and decides where it is supplied.
- Reserve Meds helps your family understand the steps, organizes records and communication, and, where an import is approved, arranges US supply through our licensed wholesale partner. We do not give medical advice.
Documents you will usually need
- The lung specialist's report confirming IPF or PPF, with the high-resolution CT report
- Recent lung function test results
- A list of current medicines, especially pirfenidone, nintedanib or any strong CYP3A inhibitor, because they change the dose plan
- For an import request: the hospital's request form, its signed declaration of responsibility, written patient consent, and proof of the US FDA approval (we can supply the US prescribing information)
Steps
- Doctor's letter. Your specialist writes the clinical letter and prescription.
- Hospital request. The hospital pharmacy files the import request with MoPH.
- Regulator decision. MoPH reviews the request and approves it or asks for more information.
- US sourcing. Our US-licensed wholesale partner supplies the medicine, shipped with tracking.
- Hospital receipt. The hospital pharmacy receives the medicine and dispenses it to the patient.
Timeline and cost
We give you a written timeline estimate for your case before you commit. The regulator, the hospital and the manufacturer set their own timelines.
Medicine price: quote on request. You get a written quote for your case before you commit. Your total cost depends on the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.
How Reserve Meds helps
Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We coordinate access to FDA-approved medicines only. We help your family understand the route, organize records and communication with the doctor and hospital, and, where an import is approved, arrange US supply and shipping through our licensed wholesale partner. Delivery follows the terms of the import approval and is confirmed in writing before you commit. We do not prescribe, and we do not decide what MoPH approves.
Ask about Jascayd in Qatar
Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.
Frequently asked questions
Is Jascayd registered in Qatar?
We could not confirm Jascayd's status in Qatar, because we found no public drug register. Ask the hospital pharmacy to confirm the current status with MoPH's Department of Pharmacy and Drug Control before anything is filed.
How do patients in Qatar get Jascayd?
In Qatar, the Ministry of Public Health (MoPH), through its Department of Pharmacy and Drug Control, supervises the registration and importation of medicines. For a medicine that is not registered in Qatar, the treating hospital asks MoPH for approval to import it for the patient. Your hospital pharmacy prepares the request and confirms the current MoPH procedure.
How long does it take to get Jascayd in Qatar?
We give you a written timeline estimate for your case before you commit. The regulator, the hospital and the manufacturer set their own timelines, and we tell you honestly what depends on them.
How much does Jascayd cost?
Medicine price: quote on request. You get a written quote for your case before you commit. Your total cost, including shipping, import steps and coordination, is quoted in writing before you commit. No hidden charges.
Can Jascayd be taken with nintedanib or pirfenidone?
The US label covers people who also take pirfenidone: they stay on 18 mg twice daily. Boehringer Ingelheim reported that diarrhea was more frequent in people also taking nintedanib. Your lung specialist decides on the combination and the dose.
Sources
Checked on 17 October 2026. Regulator rules and lists change. Your doctor, hospital pharmacy or the regulator confirms the current position before anything is filed.
- Pulmonary Fibrosis Foundation: FDA approves nerandomilast (Jascayd) for IPF (7 Oct 2025)
- Boehringer Ingelheim: U.S. FDA approves JASCAYD tablets for progressive pulmonary fibrosis in adults (BioSpace, 22 Dec 2025)
- FDA label: JASCAYD (nerandomilast) prescribing information, revised 02/2026
- Qatar Ministry of Public Health: services for companies (pharmacy and drug control)
- Abu Dhabi Department of Health: drug code list (release of 26 Sep 2026, checked 17 Oct 2026)
- Qatar medication importation note (importation is supervised by MoPH)